The eligibility criteria for both drugs is the same
This prevents some who could benefit from a GLP-1 from accessing it, but it allows the organization to maximize the value on their investment while still offering ongoing coverage
How you take it: Just one capsule after lunch every day
These hallmarks encompass genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient-sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication (Figure 1)
Phase 2 clinical trials of retatrutide, including the landmark studies published in the New England Journal of Medicine in 2023, primarily evaluated the drug's efficacy and safety in terms of weight reduction, cardiovascular markers, and gastrointestinal tolerability